• South Korea approves commercialization of Zestra biospectrumasia
    February 07, 2017
    The exclusive ten-year agreement includes a minimum of $2 million per year in sales of Zestra to the Company for a total of $20 million over the life of the ten-year term of the agreement
PharmaSources Customer Service